Idera Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 87   

Articles published

IDRA 3.51 -0.07 (-1.96%)
price chart
Company Shares of Idera Pharmaceuticals, Inc. Drops by -4.79%
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) has lost 4.79% during the past week and dropped 1.92% in the last 4 weeks.
Zacks Rating on Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) remains a strong buy in the latest set of rankings. The shares have received an average rating of 1 by 3 analysts.
Analytic Report on Idera Pharmaceuticals Inc (NASDAQ:IDRA)
Idera Pharmaceuticals Inc (NASDAQ:IDRA)(TREND ANALYSIS) a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients with cancer and rare diseases, today announced that it has appointed Mark J. Casey ...
Biotech Stocks that your portfolio will love – Idera Pharmaceuticals Inc ...  Wall Street Observer
Idera Pharmaceuticals Shares Up (IDRA) on Steady Volume  IRA Market Report
Company Shares of Idera Pharmaceuticals, Inc. Rally 8.99%
Shares of Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) rose by 8.99% in the past week and 5.62% for the last 4 weeks. In the past week, the shares have outperformed the S&P 500 by 11.45% and the outperformance increases to 6.73% for the last 4 weeks.
Idera Pharmaceuticals: Is The Writing On The Wall?
Idera Pharmaceuticals has shown recent successes in advancing their technology for treatment of many life threatening diseases, which makes it an attractive investment.
Momentum Stock in Focus: Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) has been given a top momentum style rating by Zacks Research. This rating is an indicator of when a stock might be favorable to enter a position to take advantage of the equity movement in either an upward or ...
Biotech Stocks in News - Incyte Corporation (NASDAQ:INCY), Idera ...  Wall Street Observer
Stocks Intraday Alert - Idera Pharmaceuticals Inc (IDRA), Cincinnati Bell ...  Techsonian (press release)
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Analyst Rating Update
Company has received recommendation from many analysts. JP Morgan initiates coverage on Idera Pharmaceuticals, Inc. (NASDAQ:IDRA).
2015 Year to Date Losers in Healthcare: Idera Pharmaceuticals Inc (NASDAQ ...  Wall Street Observer
Idera Pharmaceuticals Sees Large Increase in Short Interest (IDRA)  The Legacy
1-Week Top Losers in Healthcare: Idera Pharmaceuticals Inc (NASDAQ:IDRA ...
Idera Pharmaceuticals Inc (NASDAQ:IDRA), latest closing price of $3.45 is at a discount to its 200-day moving average price of $3.83.
Short Interest Update of Idera Pharmaceuticals, Inc. (NASDAQ:IDRA)
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) has witnessed a rise of 16.9% or 3,848,210 shares in its short figure. The short interest augmentation took it from 22,724,995 on June 15,2015 to 26,573,205 on June 30,2015.
Company Shares of Idera Pharmaceuticals, Inc. Drops by -4.38%  OTC Outlook
Idera Pharmaceuticals, Inc. Shares Soar On Earnings
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Idera Pharmaceuticals (IDRA) Stock Gains After Earnings  CNA Finance (press release)
Company Update (NASDAQ:IDRA): Idera Pharmaceuticals Reports First Quarter ...  Smarter Analyst